Cytarabine 25021-0229-05

Package NDC

25021-0229-05

Manufacturer: Sagent Pharmaceuticals
Dosage Form: Injection, Solution
Route: Intrathecal, Intravenous, And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: June 1, 2023
Listing Expires: December 31, 2026
Application: ANDA211937

Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cytarabine	20 mg/mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

25021-0229-05Selected

5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL